Nova Leap Health Corp.
NVLPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $25,761 | $26,179 | $28,205 | $21,279 |
| % Growth | -1.6% | -7.2% | 32.5% | – |
| Cost of Goods Sold | $15,874 | $16,411 | $18,230 | $14,068 |
| Gross Profit | $9,887 | $9,768 | $9,975 | $7,211 |
| % Margin | 38.4% | 37.3% | 35.4% | 33.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $8,440 | $8,423 | $9,682 | $7,581 |
| SG&A Expenses | $8,440 | $8,423 | $9,682 | $7,581 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $584 | $885 | -$37 | -$26 |
| Operating Expenses | $9,023 | $9,308 | $11,038 | $3,317 |
| Operating Income | $864 | $460 | -$1,062 | -$1,231 |
| % Margin | 3.4% | 1.8% | -3.8% | -5.8% |
| Other Income/Exp. Net | $948 | -$1,826 | -$144 | $3,705 |
| Pre-Tax Income | $1,812 | -$1,366 | -$1,207 | $2,473 |
| Tax Expense | $434 | -$311 | -$371 | $713 |
| Net Income | $1,378 | -$1,055 | -$836 | $1,761 |
| % Margin | 5.4% | -4% | -3% | 8.3% |
| EPS | 0.016 | -0.012 | -0.01 | 0.024 |
| % Growth | 231.1% | -18.4% | -143.8% | – |
| EPS Diluted | 0.016 | -0.012 | -0.01 | 0.023 |
| Weighted Avg Shares Out | 86,245 | 86,216 | 81,459 | 74,404 |
| Weighted Avg Shares Out Dil | 86,795 | 86,209 | 81,459 | 77,654 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $107 | $145 | $271 | $401 |
| Depreciation & Amortization | $278 | $885 | $1,302 | $854 |
| EBITDA | $1,142 | -$336 | $367 | $3,736 |
| % Margin | 4.4% | -1.3% | 1.3% | 17.6% |